GlassScriptPhysician profile
Alberto D Duran
NPI 1366527293
$883.50
in general payments reported to CMS, 2019-2025
16 companies · $94.08 in 2025
The $94.08 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $74.13 · 2021: $59.83 · 2022: $271 · 2023: $109 · 2024: $106 · 2025: $94.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $169.62 | 2022-2025 | Phexxi, Solosec, Phexx |
| Minerva Surgical, INC | $108.17 | 2019 | |
| Abbvie INC. | $100.33 | 2021-2022 | |
| Exeltis, USA INC. | $89.94 | 2019-2021 | |
| Astellas Pharma US INC | $85.27 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $63.61 | 2022-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Organon LLC | $62.43 | 2022-2024 | |
| Amag Pharmaceuticals, INC. | $41.34 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $33.74 | 2023 | Myfembree |
| Agile Therapeutics, INC. | $32.60 | 2022-2023 | Twirla |
| Myovant Sciences INC. | $22.87 | 2022 | |
| Allergan, INC. | $17.95 | 2019 | |
| Baxter Healthcare | $16.78 | 2025 | Perclot |
| Axonics, INC. | $15.96 | 2023 | Axonics |
| Duchesnay USA Incorporated | $11.57 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Duran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.